跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 460,103 条关于
“carcinoma in-situ”
全部
460,103
临床试验
415,121
药物
2,816
机构
1,379
资讯
40,787
2年前
Cretostimogene Shows High Complete Response Rate in BCG-Unresponsive Bladder Cancer
9个月前
EMA Grants Conditional Marketing Authorization for ImmunityBio's ANKTIVA in Bladder Cancer
10个月前
enGene Holdings Reports 63% Complete Response Rate in Phase 2 Bladder Cancer Gene Therapy Trial
去年
FDA-Approved Menopause Drug Duavee Shows Promise for Breast Cancer Prevention in Phase 2 Trial
10个月前
Forlong Biotechnology Initiates Phase 2 Trial of IL-15 Superagonist FL115 Combined with BCG for Non-Muscle Invasive Bladder Cancer
9个月前
EMA Recommends Conditional Approval for ImmunityBio's Anktiva in BCG-Unresponsive Bladder Cancer
9个月前
enGene's Detalimogene Selected for FDA Manufacturing Pilot Program to Accelerate Bladder Cancer Gene Therapy Development
3年前
Phase II Study Evaluates Durvalumab for BCG-Unresponsive Bladder Cancer
8个月前
enGene Secures $125 Million Debt Facility to Advance Bladder Cancer Gene Therapy Toward FDA Approval
去年
Medicus Pharma Eyes 2025 Milestones for SkinJect in Basal Cell Carcinoma
第 1 页,共 4079 页
上一页
下一页